Timezone: US/Eastern

Last Price Update:
2019-09-05 06:10:54



Ex-Dividend Calendar



Common Stock Sectors



Collections



Abbott Laboratories

Symbol: ABT     Sector: Healthcare     Industry: Medical Devices

Dividend Yield
1.54%
Current Price
$83.39
Info     Dividend Rate History     Dividend Yield History     Earnings     Financials     Rankings

Financials 2019

Update: 2019-06-09 08:40:01

Period

Report Date
Operating Revenue
Total Revenue
Cost of Revenue
Gross Profit
Operating Expense
Operating Income
Net Income
Current Assets
Total Assets
Total Liabilities
Shareholders Equity
Current Cash
Current Debt
Total Cash
Total Debt
Cash Change
Cash Flow
 
R&D

Q 1

2019-03-31
6,954,000,000
7,535,000,000
3,160,000,000
4,375,000,000
3,636,000,000
739,000,000
672,000,000
14,409,000,000
67,610,000,000
36,481,000,000
30,925,000,000
3,022,000,000
209,000,000
3,261,000,000
19,054,000,000
-826,000,000
712,000,000
 
672,000,000

Financials 2018

Update: 2019-06-09 08:40:01

Period

Report Date
Operating Revenue
Total Revenue
Cost of Revenue
Gross Profit
Operating Expense
Operating Income
Net Income
Current Assets
Total Assets
Total Liabilities
Shareholders Equity
Current Cash
Current Debt
Total Cash
Total Debt
Cash Change
Cash Flow
 
R&D

Q 4

2018-12-31
5,770,000,000
7,765,000,000
3,191,000,000
4,574,000,000
3,409,000,000
1,165,000,000
654,000,000
14,632,000,000
67,173,000,000
36,451,000,000
30,524,000,000
3,844,000,000
207,000,000
4,086,000,000
19,566,000,000
-3,507,000,000
1,765,000,000
 
562,000,000

Q 3

2018-09-30
7,656,000,000
7,656,000,000
3,166,000,000
4,490,000,000
3,495,000,000
995,000,000
563,000,000
18,196,000,000
71,637,000,000
40,739,000,000
30,705,000,000
7,369,000,000
4,274,000,000
7,550,000,000
23,558,000,000
4,331,000,000
2,183,000,000
 
574,000,000

Q 2

2018-06-30
7,767,000,000
7,767,000,000
3,282,000,000
4,485,000,000
3,603,000,000
882,000,000
733,000,000
14,122,000,000
68,415,000,000
37,641,000,000
30,577,000,000
3,065,000,000
847,000,000
3,264,000,000
20,670,000,000
-686,000,000
1,244,000,000
 
575,000,000

Q 1

2018-03-31
7,390,000,000
7,390,000,000
3,067,000,000
4,323,000,000
3,715,000,000
608,000,000
418,000,000
14,964,000,000
70,908,000,000
39,307,000,000
31,399,000,000
3,857,000,000
737,000,000
4,042,000,000
21,891,000,000
-5,585,000,000
1,108,000,000
 
589,000,000

Financials 2017

Update: 2019-06-09 08:40:01

Period

Report Date
Operating Revenue
Total Revenue
Cost of Revenue
Gross Profit
Operating Expense
Operating Income
Net Income
Current Assets
Total Assets
Total Liabilities
Shareholders Equity
Current Cash
Current Debt
Total Cash
Total Debt
Cash Change
Cash Flow
 
R&D

Q 4

2017-12-31
7,589,000,000
7,589,000,000
3,210,000,000
4,379,000,000
3,566,000,000
813,000,000
-828,000,000
20,147,000,000
76,250,000,000
45,152,000,000
30,897,000,000
9,407,000,000
714,000,000
9,610,000,000
27,924,000,000
-1,624,000,000
1,640,000,000
 
594,000,000